Guangzhou Kingmed Diagnostics Group Co., Ltd.

SHSE:603882 Stok Raporu

Piyasa değeri: CN¥14.4b

Guangzhou Kingmed Diagnostics Group Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Yaoming Liang

İcra Kurulu Başkanı

CN¥4.5m

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresino data
CEO sahipliği16.0%
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresiless than a year

Son yönetim güncellemeleri

Recent updates

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 06
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Weak Earnings May Only Reveal A Part Of The Whole Picture

Earnings Tell The Story For Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Sep 27
Earnings Tell The Story For Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Sep 03
Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

Aug 25
Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Jun 04
A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

May 02
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Apr 17
Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

Feb 28
Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

CEO

Yaoming Liang (60 yo)

no data

Görev süresi

CN¥4,503,500

Tazminat

Mr. Yaoming Liang serves as the Chairman of the Board and General Manager of Guangzhou Kingmed Diagnostics Group Co., Ltd. (formerly known as Guangzhou KingMed Center for Clinical Laboratory Co., Ltd) and...


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Yaoming Liang
Chairman & GMno dataCN¥4.50m15.96%
CN¥ 2.3b
Bixi Hao
Deputy GMno dataCN¥2.62m0.011%
CN¥ 1.6m
Linglai Wang
Deputy GM4.8yrsCN¥1.67m0.13%
CN¥ 19.2m
Ting Yan
Deputy GM & Directorno dataCN¥2.29m0.75%
CN¥ 108.8m
Huobao Xie
Independent Directorless than a yearVeri yokVeri yok
Zhanwen Zeng
Directorno dataCN¥1.04m0.75%
CN¥ 108.8m
Qiang Xie
Directorno dataVeri yokVeri yok
Jianhua Ling
Independent Directorno dataCN¥264.00kVeri yok
Yongjian Chen
Chairman of the Supervisory Boardno dataVeri yokVeri yok
Li Qin Zhou
Supervisorno dataVeri yokVeri yok
Xiaofeng Zou
Employee Representative Supervisorno dataVeri yokVeri yok
Xia Fan
Independent Directorless than a yearVeri yokVeri yok

0.8yrs

Ortalama Görev Süresi

54.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 603882 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 0.8 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.